Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12023748rdf:typepubmed:Citationlld:pubmed
pubmed-article:12023748lifeskim:mentionsumls-concept:C0000880lld:lifeskim
pubmed-article:12023748lifeskim:mentionsumls-concept:C0683598lld:lifeskim
pubmed-article:12023748lifeskim:mentionsumls-concept:C0072160lld:lifeskim
pubmed-article:12023748pubmed:issue5lld:pubmed
pubmed-article:12023748pubmed:dateCreated2002-5-22lld:pubmed
pubmed-article:12023748pubmed:abstractTextPURPOSE/METHOD: To point out that acanthamoeba keratitis can show therapeutical resistance to dibrome propamidine isethionate (Brolene). We have a late diagnosis case of corneal melting on a bilateral acanthamoeba keratitis. RESULTS/CONCLUSION: We performed corneal graft in one eye and found histopathological evidence of acanthamoeba. There was relapse in the graft in spite of Brolene treatment and good results when we changed to polyhidroxy methylbigunide (PHMB). In case of therapeutical Brolene resistance, PHMB can be an adequate alternative (Arch Soc Esp Oftalmol 2002; 77: 279-282).lld:pubmed
pubmed-article:12023748pubmed:languagespalld:pubmed
pubmed-article:12023748pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12023748pubmed:citationSubsetIMlld:pubmed
pubmed-article:12023748pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12023748pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12023748pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12023748pubmed:statusMEDLINElld:pubmed
pubmed-article:12023748pubmed:monthMaylld:pubmed
pubmed-article:12023748pubmed:issn0365-6691lld:pubmed
pubmed-article:12023748pubmed:authorpubmed-author:Ramón Y...lld:pubmed
pubmed-article:12023748pubmed:authorpubmed-author:Vaquero...lld:pubmed
pubmed-article:12023748pubmed:authorpubmed-author:Encinas...lld:pubmed
pubmed-article:12023748pubmed:authorpubmed-author:Cajigal...lld:pubmed
pubmed-article:12023748pubmed:issnTypePrintlld:pubmed
pubmed-article:12023748pubmed:volume77lld:pubmed
pubmed-article:12023748pubmed:ownerNLMlld:pubmed
pubmed-article:12023748pubmed:authorsCompleteYlld:pubmed
pubmed-article:12023748pubmed:pagination279-81lld:pubmed
pubmed-article:12023748pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12023748pubmed:meshHeadingpubmed-meshheading:12023748...lld:pubmed
pubmed-article:12023748pubmed:meshHeadingpubmed-meshheading:12023748...lld:pubmed
pubmed-article:12023748pubmed:meshHeadingpubmed-meshheading:12023748...lld:pubmed
pubmed-article:12023748pubmed:meshHeadingpubmed-meshheading:12023748...lld:pubmed
pubmed-article:12023748pubmed:meshHeadingpubmed-meshheading:12023748...lld:pubmed
pubmed-article:12023748pubmed:meshHeadingpubmed-meshheading:12023748...lld:pubmed
pubmed-article:12023748pubmed:meshHeadingpubmed-meshheading:12023748...lld:pubmed
pubmed-article:12023748pubmed:year2002lld:pubmed
pubmed-article:12023748pubmed:articleTitle[Acanthamoeba keratitis, a possible dibromo propamidine isethionate resistance].lld:pubmed
pubmed-article:12023748pubmed:affiliationHospital Universitario Clínica Puerta de Hierro, Madrid, España.lld:pubmed
pubmed-article:12023748pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12023748pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:12023748pubmed:publicationTypeCase Reportslld:pubmed